CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....
Phase 2, Phase 3
Rochester, Minnesota, United States and 60 other locations
with or without epacadostat in the treatment of recurrent glioblastoma (GBM). The investigators hypothesize that this combination p...
Phase 2
Rochester, Minnesota, United States and 3 other locations
This research study is studying several investigational drugs as a possible treatment for Glioblastoma (GBM).The drugs involved in ...
Phase 2
Rochester, Minnesota, United States and 11 other locations
This phase II trial tests the safety and side effects of efineptakin alfa and pembrolizumab in treating patients with glioblastoma that has ...
Phase 2
Rochester, Minnesota, United States
with progressive or recurrent GBM....
Phase 1, Phase 2
Rochester, Minnesota, United States and 5 other locations
This is an open-label, multicenter, randomized, parallel, 2-arm, efficacy and safety study. Patients with GBM after failure of standard firs...
Phase 2
Rochester, Minnesota, United States and 55 other locations
alone versus bevacizumab in patients diagnosed with recurrent glioblastoma (a type of brain cancer, also known as GBM), and to eval...
Phase 3
Rochester, Minnesota, United States and 112 other locations
To assess:efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification,...
Phase 2
Rochester, Minnesota, United States and 90 other locations
Clinical trials
Research sites
Resources
Legal